Research Notice: This article covers research on the CJC-1295 No DAC / Ipamorelin Blend research peptide — available from Palmetto Peptides for laboratory use only.

---

Research Use Only Disclaimer: This product is sold exclusively for in vitro and legitimate laboratory research purposes. It is not intended for human consumption, veterinary use, or any clinical application. The information in this article is for scientific and educational reference only and does not constitute medical advice. All research use must comply with applicable federal, state, and institutional regulations. Palmetto Peptides complies fully with all applicable FDA guidelines.

---

CJC-1295/Ipamorelin Blend: Storage, Stability & Shelf Life

Last Updated: October 1, 2026 | Reading Time: Approximately 9 minutes | Author: Palmetto Peptides Research Team

---

Quick Answer

Co-lyophilized CJC-1295 No DAC / Ipamorelin blend follows the same general stability rules as either peptide alone: the lyophilized powder is stable for 24+ months at -20°C and protected from light, while the reconstituted solution should be used within 20-30 days when refrigerated at 2-8°C. The open research question specific to a blend is whether combining two peptides in one co-lyophilized cake changes degradation kinetics for either compound — published accelerated-stability data on this exact combination is limited, so researchers should treat blend-specific shelf-life claims as an extrapolation from each peptide's individual stability profile, not a directly tested figure, and budget for more frequent integrity checks (clarity, pH drift, potency) than they might with a single well-characterized compound.

---

Table of Contents

• Why Blend Stability Isn't Just "Average the Two"
• Lyophilized (Pre-Reconstitution) Stability
• Reconstituted Stability and the 2-8°C Window
• Freeze-Thaw Considerations for a Two-Compound Blend
• Light, Agitation, and Container Factors
• Signs of Degradation to Check For
• Data Gap: What Hasn't Been Directly Studied
• Practical Storage Checklist
• Frequently Asked Questions

---

Why Blend Stability Isn't Just "Average the Two"

CJC-1295 No DAC (Mod GRF 1-29) and Ipamorelin are structurally distinct peptides with different amino acid sequences, molecular weights (3367.9 Da vs. 711.9 Da), and known degradation pathways. CJC-1295 No DAC, as a longer-chain GHRH analog, is generally considered more susceptible to oxidation and hydrolysis at its peptide bonds than the shorter, more conformationally rigid Ipamorelin pentapeptide. When the two are co-lyophilized into a single cake rather than packaged separately, it's reasonable to ask whether proximity, shared excipients, or the freeze-drying process itself could affect one compound's stability profile relative to how it behaves alone.

In practice, researchers in this space generally treat co-lyophilized GH secretagogue blends as behaving according to the more sensitive of the two compounds' known stability windows, as a conservative default — but this is an inference drawn from each peptide's individual literature, not a confirmed finding from head-to-head stability testing of the combined product. That distinction matters for how confidently a lab can rely on a given shelf-life number, and it's worth stating plainly rather than implying more certainty than the data supports.

---

Lyophilized (Pre-Reconstitution) Stability

Before reconstitution, both CJC-1295 No DAC and Ipamorelin are chemically stable as lyophilized powders when stored correctly:

• Temperature: -20°C (standard freezer) is the manufacturer-recommended storage condition for the unreconstituted blend, consistent with cold-chain handling for both individual compounds.
• Light exposure: Lyophilized peptides are generally photosensitive to some degree; storing vials in their original packaging or a dark container reduces unnecessary light exposure during storage.
• Moisture: The lyophilization process removes water specifically because residual moisture accelerates peptide bond hydrolysis. Vials should remain sealed until the researcher is ready to reconstitute, and should not be opened and resealed repeatedly for partial use.
• Typical shelf life: Under proper -20°C storage, lyophilized GH secretagogue peptides are commonly cited as stable for 24 months or more from the manufacture date, though researchers should always confirm the specific lot's tested shelf life against its Certificate of Analysis rather than relying on a general industry figure.

Short-term storage at standard refrigerator temperature (2-8°C) for the unreconstituted powder is generally considered acceptable for brief periods (days to a few weeks) if freezer storage isn't immediately available, but -20°C remains the standard for any extended storage window.

---

Reconstituted Stability and the 2-8°C Window

Once reconstituted with bacteriostatic water, the clock changes meaningfully. The general research-community guidance for GH secretagogue peptides reconstituted with bacteriostatic water (which contains 0.9% benzyl alcohol as a preservative) is:

• Storage condition: Refrigerated at 2-8°C, not frozen — repeated freeze-thaw cycling of a reconstituted solution is more damaging than steady refrigeration.
• Typical usable window: 20-30 days for most reconstituted GH secretagogue peptides, though this is a general guideline rather than a blend-specific validated figure.
• Why bacteriostatic water specifically: The benzyl alcohol preservative inhibits microbial growth in the reconstituted solution, which is why bacteriostatic water (not plain sterile water) is the standard reconstitution diluent for multi-use research vials.

For a two-compound blend, the practical implication is that the usable window should be governed by whichever compound degrades faster once in solution. Since there isn't published head-to-head accelerated-stability data directly comparing the blend's in-solution degradation curve against each peptide's individual curve, the conservative approach — and the one most labs in this space actually follow — is to apply the shorter of the two individually-reported windows rather than assume the blend matches the more stable compound.

---

Freeze-Thaw Considerations for a Two-Compound Blend

Repeated freezing and thawing is a known stressor for peptide solutions generally, as ice crystal formation can disrupt secondary structure and promote aggregation. For a blend containing two different peptides, this raises a specific question that single-compound stability data can't answer: do CJC-1295 No DAC and Ipamorelin respond identically to freeze-thaw stress, or could one be more vulnerable than the other within the same solution?

Without published data isolating this variable for the co-formulated product, the research-conservative practice is to treat the blend as if it has no more freeze-thaw tolerance than its least-tolerant component, and to minimize freeze-thaw cycling of reconstituted solution altogether — drawing a single use's volume at a time rather than repeatedly removing the vial from refrigeration, and never refreezing a solution that has already been reconstituted and refrigerated.

---

Light, Agitation, and Container Factors

A few handling variables apply to the blend the same way they apply to either peptide individually, but are worth restating in a blend-specific context since both compounds share a single vial and handling event:

• Avoid vigorous shaking. Mechanical agitation during or after reconstitution can promote aggregation in either peptide. Gentle swirling until the cake fully dissolves is the standard technique.
• Keep vials away from direct light during both lyophilized and reconstituted storage, including avoiding unnecessary time on a lit benchtop.
• Use the original glass vial for storage rather than transferring solution to another container, which introduces contamination risk and unverified compatibility with the new container's material.

---

Signs of Degradation to Check For

Regardless of how carefully a blend has been stored, a visual and practical check before each use is good laboratory practice:

• Clarity: The reconstituted solution should be clear and colorless. Cloudiness, haziness, or visible particulates indicate the solution should be discarded.
• Discoloration: Any yellowing or color change from the original clear solution is a signal of possible degradation.
• Unexpected residue: Precipitate at the bottom of the vial after proper reconstitution (not simply undissolved lyophilized cake) suggests aggregation.
• Time since reconstitution: Track and label the reconstitution date on every vial. A solution within its stated window but showing any of the above signs should still be discarded — visual integrity checks override calendar-based assumptions.

---

Data Gap: What Hasn't Been Directly Studied

In the interest of accurate research framing rather than overstating certainty: publicly available accelerated-stability studies (forced degradation under elevated temperature, humidity, or light to model real-world shelf life) specific to a co-lyophilized CJC-1295 No DAC / Ipamorelin combination are not something Palmetto Peptides is aware of in the current peer-reviewed or manufacturer-published literature. The storage guidance above is a research-conservative synthesis built from each peptide's individually documented stability behavior, standard peptide chemistry principles, and common practice among labs working with co-formulated GH secretagogue blends — not a citation to a study that tested this exact blended product's degradation curve directly. Researchers designing studies where precise shelf-life data matters to their results should consider running their own stability characterization on their specific lot, or request available stability data directly from Palmetto Peptides' COA documentation for the lot in use.

---

Practical Storage Checklist

• Store unreconstituted vials at -20°C, protected from light, until ready to use.
• Reconstitute with bacteriostatic water only, using gentle swirling — never shake.
• Label every reconstituted vial with the reconstitution date.
• Refrigerate reconstituted solution at 2-8°C; do not refreeze.
• Use reconstituted solution within the shorter of the two compounds' typical windows (practically, 20-30 days as a conservative outer bound) and inspect visually before every use.
• Discard immediately if the solution shows cloudiness, discoloration, or precipitate, regardless of how much time has elapsed.

---

Frequently Asked Questions

Q: Does the blend expire faster than CJC-1295 No DAC or Ipamorelin alone?
A: There's no published data showing it degrades faster, but there's also no published data confirming it degrades at the same rate. The conservative research approach is to apply the more cautious of the two compounds' individual stability windows rather than assume the blend matches the hardier one.

Q: Can I store the reconstituted blend at room temperature for convenience?
A: This isn't the recommended approach. Refrigeration at 2-8°C is the standard guidance for reconstituted GH secretagogue peptides, including this blend, to slow degradation and limit microbial growth risk.

Q: Is it safe to freeze the blend after reconstitution to extend its usable life?
A: Freeze-thaw cycling of reconstituted peptide solution is generally considered more damaging than steady refrigeration, and this hasn't been specifically validated as safe for this blend. Reconstitute only the volume you expect to use within the refrigerated window.

Q: How do I know if my specific lot has different stability data than general guidance?
A: Check the lot's Certificate of Analysis, and reach out to Palmetto Peptides directly if lot-specific stability data is needed for a study design that depends on precise shelf-life figures.

Related Research: CJC-1295/Ipamorelin Blend: Reconstitution & Dosing Guide | CJC-1295 Storage & Stability | Ipamorelin Storage & Stability

For laboratory research use only. Not for human consumption. Not evaluated by the FDA.